125 related articles for article (PubMed ID: 10965500)
21. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
22. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
Bollig A; Miksicek RJ
Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
[TBL] [Abstract][Full Text] [Related]
23. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.
Levy N; Zhao X; Tang H; Jaffe RB; Speed TP; Leitman DC
Endocrinology; 2007 Jul; 148(7):3449-58. PubMed ID: 17395694
[TBL] [Abstract][Full Text] [Related]
24. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements.
Hall JM; McDonnell DP; Korach KS
Mol Endocrinol; 2002 Mar; 16(3):469-86. PubMed ID: 11875105
[TBL] [Abstract][Full Text] [Related]
25. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.
Shiau AK; Barstad D; Loria PM; Cheng L; Kushner PJ; Agard DA; Greene GL
Cell; 1998 Dec; 95(7):927-37. PubMed ID: 9875847
[TBL] [Abstract][Full Text] [Related]
26. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells.
Pak TR; Chung WC; Lund TD; Hinds LR; Clay CM; Handa RJ
Endocrinology; 2005 Jan; 146(1):147-55. PubMed ID: 15471969
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action.
Koohi MK; Ivell R; Walther N
J Neuroendocrinol; 2005 Apr; 17(4):197-207. PubMed ID: 15842231
[TBL] [Abstract][Full Text] [Related]
28. Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells.
Sun J; Nawaz Z; Slingerland JM
Mol Endocrinol; 2007 Nov; 21(11):2651-62. PubMed ID: 17666587
[TBL] [Abstract][Full Text] [Related]
29. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.
Schaufele F; Chang CY; Liu W; Baxter JD; Nordeen SK; Wan Y; Day RN; McDonnell DP
Mol Endocrinol; 2000 Dec; 14(12):2024-39. PubMed ID: 11117532
[TBL] [Abstract][Full Text] [Related]
30. An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription.
Jeffy BD; Hockings JK; Kemp MQ; Morgan SS; Hager JA; Beliakoff J; Whitesell LJ; Bowden GT; Romagnolo DF
Neoplasia; 2005 Sep; 7(9):873-82. PubMed ID: 16229810
[TBL] [Abstract][Full Text] [Related]
31. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
Dutertre M; Smith CL
Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
[TBL] [Abstract][Full Text] [Related]
32. Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA.
Anolik JH; Klinge CM; Bambara RA; Hilf R
J Steroid Biochem Mol Biol; 1993 Dec; 46(6):713-30. PubMed ID: 8274405
[TBL] [Abstract][Full Text] [Related]
33. Non-classical regulation of estrogen receptor-alpha by ICI182,780.
Wang MM; Traystman RJ; Hurn PD; Liu T
J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):51-62. PubMed ID: 15544930
[TBL] [Abstract][Full Text] [Related]
34. Structure-function evaluation of ER alpha and beta interplay with SRC family coactivators. ER selective ligands.
Wong CW; Komm B; Cheskis BJ
Biochemistry; 2001 Jun; 40(23):6756-65. PubMed ID: 11389589
[TBL] [Abstract][Full Text] [Related]
35. High-affinity anti-oestrogen binding site distinct from the oestrogen receptor.
Sutherland RL; Murphy LC; San Foo M; Green MD; Whybourne AM; Krozowski ZS
Nature; 1980 Nov; 288(5788):273-5. PubMed ID: 7432524
[TBL] [Abstract][Full Text] [Related]
36. Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors.
Cherlet T; Murphy LC
Mol Cell Biochem; 2007 Dec; 306(1-2):33-42. PubMed ID: 17660955
[TBL] [Abstract][Full Text] [Related]
37. Differences between oestrogen receptor activation by oestrogen and antioestrogen.
Rochefort H; Borgna JL
Nature; 1981 Jul; 292(5820):257-9. PubMed ID: 7254318
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway.
Feng W; Webb P; Nguyen P; Liu X; Li J; Karin M; Kushner PJ
Mol Endocrinol; 2001 Jan; 15(1):32-45. PubMed ID: 11145737
[TBL] [Abstract][Full Text] [Related]
39. Suppression by estrogen receptor beta of AP-1 mediated transactivation through estrogen receptor alpha.
Maruyama S; Fujimoto N; Asano K; Ito A
J Steroid Biochem Mol Biol; 2001 Aug; 78(2):177-84. PubMed ID: 11566442
[TBL] [Abstract][Full Text] [Related]
40. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens.
Fritah A; Redeuilh G; Sabbah M
J Endocrinol; 2006 Dec; 191(3):613-24. PubMed ID: 17170219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
